CS logo
small CS logo
Internistische Gemeinschaftspraxis - Oldenburg

Oldenburg, Germany
Internist in Oldenburg, Lower Saxony
Bürgerbuschweg, 26127, Neue Donnerschweer Str. 30, 26123 Oldenburg

About Internistische Gemeinschaftspraxis - Oldenburg


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Internistische Gemeinschaftspraxis - Oldenburg


During the past decade, Internistische Gemeinschaftspraxis - Oldenburg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000000110000000000Started TrialsCompleted Trails2018201920202021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
2004-10-01
2009-10-01
Completed
60
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
2005-10-01
2015-06-01
Completed
825
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
2004-09-01
2010-10-01
Completed
97
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Internistische Gemeinschaftspraxis - Oldenburg" #1 sponsor was "German CLL Study Group" with 6 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Janssen-Cilag Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Internistische Gemeinschaftspraxis - Oldenburg" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGerman CLL Study Group: 6German CLL Study Group: 6German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 1German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Janssen-Cilag Ltd.: 1Janssen-Cilag Ltd.: 1

Created with Highcharts 11.1.0Top CollaboratorsGerman CLL Study Group: 1German CLL Study Group: 1

Clinical Trials Conditions at Internistische Gemeinschaftspraxis - Oldenburg


According to Clinical.Site data, the most researched conditions in "Internistische Gemeinschaftspraxis - Oldenburg" are "Chronic Lymphocytic Leukemia" (6 trials), "Crohn Disease" (2 trials), "Anemia" (1 trials), "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Internistische Gemeinschaftspraxis - Oldenburg" in a lesser frequency.

Clinical Trials Intervention Types at Internistische Gemeinschaftspraxis - Oldenburg


Most popular intervention types in "Internistische Gemeinschaftspraxis - Oldenburg" are "Drug" (10 trials), "Biological" (4 trials), "Radiation" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Fludarabine" (3 trials), "Cyclophosphamide" (2 trials), "Rituximab" (2 trials), "cyclophosphamide" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Internistische Gemeinschaftspraxis - Oldenburg


The vast majority of trials in "Internistische Gemeinschaftspraxis - Oldenburg" are 10 trials for "All" genders.

Clinical Trials Status at Internistische Gemeinschaftspraxis - Oldenburg


Currently, there are NaN active trials in "Internistische Gemeinschaftspraxis - Oldenburg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Internistische Gemeinschaftspraxis - Oldenburg, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Internistische Gemeinschaftspraxis - Oldenburg, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Recruiting: 1Recruiting: 1